The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens.
The World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) have jointly released a landmark report unveiling critical findings on the persistent and preventable threat of contaminated medicines which claimed the lives and compromised the health of countless patients, predominantly children, through the ingestion of medicines with dangerously high levels of ...
Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommendation 2025 (English)
Recent research has found that promotion of prescription drugs by social media influencers is often associated with misleading information.
The promotion of prescription drugs by social media influencers is growing. This type of promotion carries public health risks, authors of a systematic review said. Recurrent themes in posts about ...